echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Infection with COVID-19 increases the risk of long-term brain damage

    Infection with COVID-19 increases the risk of long-term brain damage

    • Last Update: 2022-10-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    【International War "Epidemic" Action】

    Science and Technology Daily News (Intern reporter Zhang Jiaxin) Researchers at the University of Washington School of Medicine reported on September 22 that people with new crown pneumonia have a higher
    risk of brain damage after one year than people who have never been infected with the new crown virus.


    People infected with COVID-19 had a 7%
    higher incidence of brain and other neurological disorders compared to similar veterans who had never been infected with COVID-19.


    The researchers looked at the medical records of 154,000 U.


    Memory impairment, often referred to as brain fog
    .


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.